At the time of this writing, we are only a couple of months away from the two-year anniversary of the FDA’s issuance of the Computer Software Assurance for Production and Quality System Software, Draft Guidance for Industry and Food and Drug and Administrative Staff.

As we approach this milestone, it’s essential to understand the regulatory landscape that governs software validation in the life sciences industry.

Introduction to FDA’s Regulatory Requirements on Software and Computer Systems

The Food and Drug Administration (FDA) plays a critical role in ensuring the safety and efficacy of medical devices and pharmaceuticals. One of the essential aspects of regulatory compliance is software validation, which ensures that computer systems perform their intended functions consistently and reliably. Within this framework, the FDA has established guidelines for Computer System Validation (CSV) and introduced the concept of Computer Software Assurance (CSA) to streamline and enhance the validation process.

What is Computer System Validation (CSV)?

Definition and Purpose

Computer System Validation (CSV) is a comprehensive process that involves documenting and testing software systems to confirm that they meet predetermined specifications and requirements. CSV aims to ensure that software used in regulated environments, such as medical devices and pharmaceutical manufacturing, operates correctly and produces reliable results. 

CSV is an older method of software (system) validation which involves extensive time and documentation (provision of objective evidence) required by the FDA to prove that software meets user needs and does what it is designed to do. CSV Involves testing to provide proof and verification of installation of IQ (Installation Qualification), OQ (Operational Qualification) and PQ (Performance Qualification). 

Key Requirements and Guidelines

• Documentation: Thorough documentation of all processes, requirements and testing procedures.
• Testing: Rigorous testing to verify that the software performs as intended.
• Traceability: Ensuring traceability from requirements to implementation and testing.
• Change Control: Managing changes to the software and its environment to maintain validation status.

Benefits of Implementing CSV

• Regulatory Compliance: Ensures adherence to FDA regulations, minimizing the risk of non-compliance.
• Quality Assurance: Enhances the reliability and accuracy of software systems.
• Risk Mitigation: Identifies and mitigates potential risks associated with software failures

How is CSV Related to FDA’s CFR Part 11? 

• CSV is a critical component of 21 CFR Part 11 compliance, requiring manufacturers to ensure that computer systems used for electronic records and signatures are reliable, secure, and function as intended. 
• It applies to computerized systems that create, modify, maintain, archive, retrieve, or transmit electronic records and signatures in FDA-regulated industries such as the Life Sciences industry.

What is Computer Software Assurance (CSA)?

Definition and Purpose

Computer Software Assurance (CSA) is a newer approach introduced by the FDA to streamline the validation process by focusing on critical thinking, risk-based assessment, and automation. CSA aims to make the validation process more efficient and less burdensome while maintaining high standards of quality and compliance.

The FDA introduced this draft guidance to foster life sciences industry use of innovation and help the regulated entities keep pace with changing technology, all while promoting compliance with FDA Computer System Validation (CSV) and Quality System requirements such as CFR Part 820.70.

How Industry Feedback and GAMP Guidelines Shape FDA’s Risk-Based Approach to CSV Compliance

The guidance followed feedback from industry participants such as the Medical Device Innovation Consortium, and their concerns about the cost and burden of CSV compliance. Also, from the pharmaceutical industry, the FDA aligned with the International Society of Pharmaceutical Engineers’ guidelines entitled “Good Automated Manufacturing Practice” (GAMP 4 and GAMP 5), which also suggest a risk-based approach to compliant software validation. 

The ISPE states: “GAMP aims to achieve computerized systems that are fit for intended use and meet current regulatory requirements by building upon existing industry good practice in an efficient and effective manner.  GAMP® adopts a patient-centric risk-based approach that enables innovation while demonstrating compliance with regulatory requirements.” It is certainly obvious why the FDA can appreciate the ISPE’s GAMP initiative.

While the CSA’s risk-based approach does not eliminate or replace computer system validation requirements, it should reduce the cost and time burden of compliance on manufacturers, and allow them to more easily leverage technological advancements to produce safe and high quality products for patients efficiently. CSA addresses the unintended consequence of CSV, which is slower adoption of new technologies that would ultimately benefit patients.

CSA’s Key Differences from CSV

CSA does not take a “test every software and its components equally” approach. CSA puts more emphasis on risk-based analysis to determine appropriate software assurance activities, reducing unnecessary testing. It also allows manufacturers to rely on vendor testing and validation activities, rather than “testing what has already been tested” by the software vendor. CSA aligns with a broader industry shift away from an older method of software validation. The FDA encourages the use of CSA to reduce the amount of work involved in meeting the required computer system validation requirements. 

• Risk-Based Approach: Emphasizes assessing and addressing risks based on the software’s impact on product quality and patient safety.
• Critical Thinking: Encourages the use of professional judgment and critical thinking in validation activities.
• Automation: Promotes the use of automated testing tools and methods to enhance efficiency.

Benefits of Implementing CSA

• Efficiency: Reduces the time and resources required for validation.
• Flexibility: Allows for a more tailored approach based on the specific risks and needs of the software.
• Innovation: Encourages the adoption of modern technologies and methodologies in the validation process.

Comparing CSV and CSA

Regulatory Compliance

Both CSV and CSA are designed to ensure compliance with FDA regulations, but CSA provides a more flexible framework that can adapt to the unique needs of different software systems. CSV focuses on detailed documentation and predefined processes, while CSA allows for a more dynamic approach based on risk assessment and critical thinking.

Risk Management

CSV traditionally involves extensive documentation and testing for all aspects of the software, regardless of risk level. In contrast, CSA emphasizes a risk-based approach, focusing resources on areas with the highest potential impact on product quality and patient safety.

Resource Requirements

CSV can be resource-intensive due to its comprehensive documentation and testing requirements. CSA aims to reduce the burden by allowing for a more streamlined, risk-based approach, potentially lowering the overall resource requirements.

Implementing CSV and CSA in Practice

Best Practices for Implementing CSV

• Comprehensive Documentation: Maintain detailed records of all validation activities.
• Robust Testing: Conduct thorough testing to ensure software reliability.
• Change Management: Implement a strict change control process to maintain validation status.

Best Practices for Implementing CSA

• Risk Assessment: Perform a thorough risk assessment to prioritize validation activities.
• Critical Thinking: Use professional judgment to determine the most appropriate validation methods.
• Automation: Leverage automated tools to enhance efficiency and accuracy.

What is the difference between “computer system validation” and “computerized system validation?  

In many contexts, the FDA uses these terms somewhat interchangeably. For example, in the guidance on “Computerized Systems Used in Clinical Investigations”, the FDA refers to both “computerized systems” and “computer systems” without making a clear distinction. In general, “computerized system” tends to refer more broadly to technical components and the associated processes and personnel. Nonetheless, the validation process described by the FDA applies similarly whether they are referring to a “computer system” or a “computerized system.”  Regardless of the term used, the FDA’s goal is to ensure that the system/computerized system consistently produces expected results and meets regulatory requirements.

Planning your approach to software validation

CSV remains a reliable and comprehensive approach for ensuring regulatory compliance, while incorporating CSA offers a more flexible and efficient framework to support a modern validation approach. By understanding the differences and benefits of CSA and CSV, organizations can make informed decisions to optimize their software validation processes and ensure compliance with FDA requirements.

The CSA guidance offers valuable recommendations for implementing a risk-based approach to computer system validation. While providing welcome relief, it also emphasizes manufacturers’ freedom to think critically beyond mere regulatory compliance. The guidance encourages evaluation of the biggest areas of risk to patients, and prioritizing heavier validation efforts on processes with the greatest impact on patient safety and product quality, while minimizing time spent on software components and processes unrelated to both. This flexibility allowing for subjectivity has led to lingering questions about CSA.

Join the CSV/CSA Conversation with Life Science Industry Experts

Are you using a risk-based approach to computer software validation? What questions, concerns or challenges does your organization have regarding CSA? 

Comment below or contact our experts with any questions, and for an invitation to our Life Sciences Roundtable lunch at QAD Transform Americas 2024 where we will continue the discussion on ways to stay compliant and lighten the administrative burden of computer software validation.